Caso Clínico 3: Hepatomegalia, dislipemia e hipertransaminasemia
Mignani R, Biagini E, Cianci V, Pieruzzi F, Pisani A et al.
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice.
Adv Ther. 2025;42:597-635
Hoffmann B, Schwarz M, Mehta A, Keshav S;
Fabry Outcome Survey European Investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy.
Clin Gastroenterol Hepatol. 2007 ;5:1447-53